Veterinary Medicines

EFICUR 50 mg/ml suspension for injection for pigs and cattle

Authorised
This information is not available for this product.
Download as PDF

Product identification

Medicine name:
EFICUR 50 mg/ml suspension for injection for pigs and cattle
EFICUR 50 mg/ml suspenzija za injiciranje za prašiče in govedo
Active substance:
This information is not available for this product.
Target species:
  • Pig
  • Cattle
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        5
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        8
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DD90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:
  • Type II glass bottle of 50 ml.The bottles are closed with a Type I bromobutyl closure and aluminium capPack size:Cardboard box with 1 glass bottle of 50 ml.
  • Type II glass bottle of 100 ml.The bottles are closed with a Type I bromobutyl closure and aluminium capPack size:Cardboard box with 1 glass bottle of 100 ml.
  • Type II glass bottle of 250 ml.The bottles are closed with a Type I bromobutyl closure and aluminium capThe 250 ml glass bottle has a colourless plastic package as a protective measure in order to avoid glass bottle breaking when itis being used.Pack size:Cardboard box with 1 glass bottle of 250 ml.
  • Type II glass bottles of 100 ml.The bottles are closed with a Type I bromobutyl closure and aluminium capPack size:Cardboard box with 10 glass bottles of 100 ml.
  • Type II glass bottles of 100 ml.The bottles are closed with a Type I bromobutyl closure and aluminium capPack size:Cardboard box with 12 glass bottles of 100 ml.
  • Polyethylene terephthalate (PET) bottle of 50 ml.The bottles are closed with a Type I bromobutyl closure and aluminium capPack size:Cardboard box with 1 PET bottle of 50 ml.
  • Polyethylene terephthalate (PET) bottle of 100 ml.The bottles are closed with a Type I bromobutyl closure and aluminium capPack size:Cardboard box with 1 PET bottle of 100 ml.
  • Polyethylene terephthalate (PET) bottle of 250 ml.The bottles are closed with a Type I bromobutyl closure and aluminium capPack size:Cardboard box with 1 PET bottle of 250 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • MR/V/0105/001
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0190/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
Slovenian (PDF)
Published on: 3/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 3/03/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 3/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."